(Hypertension. 1996;27:885-892.)
© 1996 American Heart Association, Inc.
Articles |
Effects and Interactions of Endothelin-1 and Angiotensin II on Matrix Protein Expression and Synthesis and Mesangial Cell Growth
From the Renal Research Laboratory, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
Correspondence to Jesús Egido, MD, Renal Research Laboratory, Fundación Jiménez Díaz, Avda Reyes Católicos 2, 28040 Madrid, Spain.
Abstract Mesangial cell growth and accumulation of extracellular matrix proteins constitute key features of progressive glomerular injury. Endothelin-1 (ET-1) and angiotensin II (Ang II), two potent vasoconstrictor agents, evoke a number of similar responses in mesangial cells. In rat mesangial cells, we compared ET-1 and Ang II effects on matrix protein production and cell proliferation as well as the potential interaction between the two hormones. When cells in 0.5% fetal calf serum were incubated for 24 hours with various concentrations of ET-1 or Ang II, both peptides stimulated, in a dose-dependent manner, fibronectin and type IV collagen mRNA expression, fibronectin synthesis, and mitogenesis. Incubation with specific receptor antagonists of both hormones demonstrated that endothelin subtype A (ETA) and angiotensin type 1 (AT1) receptors were involved. Preincubation of cells with two different protein kinase C inhibitors or with a neutralizing anti–transforming growth factor-ß antibody, but not an unrelated IgG, diminished the peptide-induced fibronectin synthesis. A dual interrelation seems to exist between ET-1 and Ang II. Thus, the AT1 receptor antagonist losartan and the angiotensin-converting enzyme inhibitors quinaprilat and captopril diminished the ET-1–mediated effects, whereas the ETA receptor antagonist BQ-123 diminished the Ang II–induced fibronectin synthesis and mesangial cell proliferation. Our results suggest that ET-1 and Ang II stimulate matrix protein synthesis and mesangial cell mitogenesis through ETA and AT1 receptors, respectively, by complicated mechanisms, implicating protein kinase C activation, synthesis of transforming growth factor-ß, and release of one peptide by the other. These data could be important for a better understanding of the participation of vasoactive substances in the pathogenesis of glomerulosclerosis.
Key Words: endothelin • angiotensin II • mesangial cells • matrix proteins • protein kinases • transforming growth factors • angiotensin-converting enzyme inhibitors
This article has been cited by other articles:
 |
|
 |
|
  S. He, G. Prasanna, and T. Yorio Endothelin-1-Mediated Signaling in the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Astrocytes Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3737 - 3745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Yano, D. Suzuki, M. Endoh, T. C. Zhao, J. F. Padbury, and Y.-T. Tseng A Novel Phosphoinositide 3-Kinase-dependent Pathway for Angiotensin II/AT-1 Receptor-mediated Induction of Collagen Synthesis in MES-13 Mesangial Cells J. Biol. Chem., June 29, 2007; 282(26): 18819 - 18830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. El Chaar, J. Chen, S. V. Seshan, S. Jha, I. Richardson, S. R. Ledbetter, E. D. Vaughan Jr, D. P. Poppas, and D. Felsen Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1291 - F1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Sasser, J. C. Sullivan, J. L. Hobbs, T. Yamamoto, D. M. Pollock, P. K. Carmines, and J. S. Pollock Endothelin A Receptor Blockade Reduces Diabetic Renal Injury via an Anti-Inflammatory Mechanism J. Am. Soc. Nephrol., January 1, 2007; 18(1): 143 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Rufanova and A. Sorokin CrkII Associates with BCAR3 in Response to Endothelin-1 in Human Glomerular Mesangial Cells. Experimental Biology and Medicine, June 1, 2006; 231(6): 752 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Uchide and K. Saida Primary structure of cat preproendothelin-2 and cat renal mRNA expression of preproendothelin-1 and preproendothelin-2 in naturally occurring renal failure. Experimental Biology and Medicine, June 1, 2006; 231(6): 997 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gomez-Garre, M. Herraiz, M. L. Gonzalez-Rubio, R. Bernal, P. Aragoncillo, A. Carbonell, J. J. Rufilanchas, and A. Fernandez-Cruz Activation of peroxisome proliferator-activated receptor-{alpha} and -{gamma} in auricular tissue from heart failure patients Eur J Heart Fail, March 1, 2006; 8(2): 154 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chahdi, B. Miller, and A. Sorokin Endothelin 1 Induces {beta}1Pix Translocation and Cdc42 Activation via Protein Kinase A-dependent Pathway J. Biol. Chem., January 7, 2005; 280(1): 578 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sorokin and D. E. Kohan Physiology and pathology of endothelin-1 in renal mesangium Am J Physiol Renal Physiol, October 1, 2003; 285(4): F579 - F589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Liang, H. Zhang, A. Zhou, and H. Wang AngRem104, an Angiotensin II-Induced Novel Upregulated Gene in Human Mesangial Cells, Is Potentially Involved in the Regulation of Fibronectin Expression J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1443 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hua, S. Munk, and C. I. Whiteside Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction Am J Physiol Renal Physiol, February 1, 2003; 284(2): F303 - F312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Morrissey, G. Guo, K. Moridaira, M. Fitzgerald, R. McCracken, T. Tolley, and S. Klahr Transforming Growth Factor-{beta} Induces Renal Epithelial Jagged-1 Expression in Fibrotic Disease J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1499 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tsiani, P. Lekas, I. G. Fantus, J. Dlugosz, and C. Whiteside High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E161 - E169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Amann, A. Simonaviciene, T. Medwedewa, A. Koch, S. Orth, M.-L. Gross, C. Haas, A. Kuhlmann, W. Linz, B. Scholkens, et al. Blood Pressure-Independent Additive Effects of Pharmacologic Blockade of the Renin-Angiotensin and Endothelin Systems on Progression in a Low-Renin Model of Renal Damage J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2572 - 2584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fakhouri, S. Placier, R. Ardaillou, J.-C. Dussaule, and C. Chatziantoniou Angiotensin II Activates Collagen Type I Gene in the Renal Cortex and Aorta of Transgenic Mice through Interaction with Endothelin and TGF-{beta} J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2701 - 2710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Dumont, M. D'Amours, M. Lebel, and R. Lariviere Supplementation with a low dose of l-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats Nephrol. Dial. Transplant., April 1, 2001; 16(4): 746 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yao, T. Morioka, B. Li, and T. Oite Endothelin is a potent inhibitor of matrix metalloproteinase-2 secretion and activation in rat mesangial cells Am J Physiol Renal Physiol, April 1, 2001; 280(4): F628 - F635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gomez-Garre, R. Largo, N. Tejera, J. Fortes, F. Manzarbeitia, and J. Egido Activation of NF-{{kappa}}B in Tubular Epithelial Cells of Rats With Intense Proteinuria : Role of Angiotensin II and Endothelin-1 Hypertension, April 1, 2001; 37(4): 1171 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Luscher and M. Barton Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs Circulation, November 7, 2000; 102(19): 2434 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koyanagi, K. Egashira, S. Kitamoto, W. Ni, H. Shimokawa, M. Takeya, T. Yoshimura, and A. Takeshita Role of Monocyte Chemoattractant Protein-1 in Cardiovascular Remodeling Induced by Chronic Blockade of Nitric Oxide Synthesis Circulation, October 31, 2000; 102(18): 2243 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Cao, M. E. Cooper, L. L. Wu, A. J. Cox, K. Jandeleit-Dahm, D. J. Kelly, and R. E. Gilbert Blockade of the Renin-Angiotensin and Endothelin Systems on Progressive Renal Injury Hypertension, October 1, 2000; 36(4): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kusaka, R. A. Kelly, G. H. Williams, and I. Kifor Coronary microvascular endothelial cells cosecrete angiotensin II and endothelin-1 via a regulated pathway Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1087 - H1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Neugarten, A. Acharya, J. Lei, and S. Silbiger Selective estrogen receptor modulators suppress mesangial cell collagen synthesis Am J Physiol Renal Physiol, August 1, 2000; 279(2): F309 - F318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-J. Hsieh, S.-R. Lin, Y.-J. Lee, S.-J. Shin, Y.-H. Lai, C.-H. Hsu, and J.-H. Tsai Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats Am J Physiol Renal Physiol, July 1, 2000; 279(1): F112 - F121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Brochu, S. Lacasse-M., C. Moreau, M. Lebel, I. Kingma, J. H. Grose, and R. Lariviere Endothelin ETA receptor blockade prevents the progression of renal failure and hypertension in uraemic rats Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1881 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Dlugosz, S. Munk, X. Zhou, and C. I. Whiteside Endothelin-1-induced mesangial cell contraction involves activation of protein kinase C-alpha , -delta , and -epsilon Am J Physiol Renal Physiol, September 1, 1998; 275(3): F423 - F432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Largo, D. Gomez-Garre, X. H. Liu, J. Alonso, J. Blanco, J. J. Plaza, and J. Egido Endothelin-1 Upregulation in the Kidney of Uninephrectomized Spontaneously Hypertensive Rats and Its Modification by the Angiotensin-Converting Enzyme Inhibitor Quinapril Hypertension, May 1, 1997; 29(5): 1178 - 1185. [Abstract] [Full Text]
|
|
|
|
|
|
I. Lehrke, M. Schaier, K. Schade, C. Morath, R. Waldherr, E. Ritz, and J. Wagner Retinoid receptor-specific agonists alleviate experimental glomerulonephritis Am J Physiol Renal Physiol, April 1, 2002; 282(4): F741 - F751. [Abstract] [Full Text] [PDF]
|
|